Skip to main content
SpringerLink
Log in

Biological Means Against Bio-Terrorism: Phage Therapy and Prophylaxis Against Pathogenic Bacteria

  • Conference paper
  • First Online:
Biodefence

  • 714 Accesses

Abstract

This review describes the use of bacteriophages against bacterial infections in the battlefield and protection of the civilian population. High therapeutic and protective potential of bacteriophages suggests that they could be an efficient means against bio-terrorist attacks.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegrist DW (1999) The threat of biological attack: Why concern now? Emerg Infect Dis 5:505–508

    Article  PubMed  CAS  Google Scholar 

  2. Twort FW (1915) An investigation on the nature of the ultra-microscopic viruses. Lancet 1241–1243

    Google Scholar 

  3. d’Herelle F (1917) Sur un microbe invisible antagoniste des bacilles dysentériques. C R Acad Sci Se 165:373–375

    Google Scholar 

  4. Beridze MA (1938) Role of bacteriophage therapy in combating of purulent skin infections. Tbilisi, Georgia

    Google Scholar 

  5. Ukelis II (1946) Treatment of furunculosis and other purulent skin infections with di-phage. Sovetskaia Meditsina (Russian “Soviet Medicine”) 3:11–12

    Google Scholar 

  6. Vartapetov LI (1941) Predictive significance of correspondence of the results of in vivo and in vitro lysis in case of treatment of piodermatitis, Selected Papers. Institute of Dermatology and Venereal Diseases, Tbilisi, Georgia, pp 93–97

    Google Scholar 

  7. Vartapetov LI (1947) Results of phage therapy of deep forms of piodermitis. Selected Papers. Institute of Dermatology and Venereal Diseases, Tbilisi, Georgia, pp 205–207

    Google Scholar 

  8. Vartapetov LI (1957) Phage therapy of deep forms of piodermitis caused by Staphylococcus, In “Bacteriophages”, Tbilisi, Georgia, pp 411–422

    Google Scholar 

  9. Khuskivadze ZF (1954) On the issue of phage therapy of deep forms of piodermitis. CandSci Diss, Tbilisi, Georgia

    Google Scholar 

  10. Gvazava AI (1957) Results of therapy of deep forms of piodermitis with the expired phage preparations. CandSci Diss, Tbilisi, Georgia

    Google Scholar 

  11. Shvelidze KD (1970) Treatment of deep forms of dermatitis of Staphylococcus etiology performed with the specific bacteriophage and some immune reactions of the organism. CandSci Diss, Tbilisi, Georgia

    Google Scholar 

  12. Rodigina AM (1938) Pneumococcal bacteriophage: Its application for treatment of the ulcerous corneal serpens. Perm, USSR

    Google Scholar 

  13. Cherkasskaja RS (1984) Application of bacteriophages for treatment of purulent conjunctivitis among newborns. Materials of the Symposium dedicated to 60th anniversary of the Tbilisi Scientific-Research Institute of Vaccine and Sera. Tbilisi, Georgia, pp 264–266

    Google Scholar 

  14. Protopopov SV (1974) Treatment of the experimental corneal ulcer caused by Staphylococcus aureus. Materials of the Scientific Symposium dedicated to the 50th anniversary of the Tbilisi Scientific Research Institute of Vaccine and Sera. Tbilisi, Georgia, pp 422–424

    Google Scholar 

  15. Samsygina GA (1985) Festering inflammatory infections among newborns (Etiology, risk factors, clinic and immune diagnostic criteria and strategy of treatment). DSc Diss, Moscow, Russia

    Google Scholar 

  16. Tsistishvili GI (1940) On the issue of phage application for puerperial infectious diseases. Akusherstvo i ginekologia (Russian “Obstetrics and Gynecology”) 12:20–22

    Google Scholar 

  17. Purtseladze MD (1941) Treatment of purulent forms of mastititis. Akusherstvo i ginekologia (Russian “Obstetrics and Gynecology”) 11–12:22–24.

    Google Scholar 

  18. Bochorishvili EV (1988) Method of treatment of tube infertility of the inflammatory genesis. SU Patent N 1395331

    Google Scholar 

  19. Tsulukidze AP (1940) Phage treatment in surgery. Khirurgiia (Russian “Surgery”) 12:132–133

    Google Scholar 

  20. Tsulukidze AP (1957) Results of phage application for treatment of surgical infections. In: Bacteriophages. Tbilisi, Georgia, pp 99–108

    Google Scholar 

  21. Tsulukidze AP (1938) Application of phages in urology. Urologiia (Russian “Urology”) 15:10–13

    Google Scholar 

  22. Ioseliani GG, Meladze GD, Chkhetiia NSh et al (1980) Use of bacteriophage and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases. Grudnaia Khirurgiia (Russian Breast Surgery) 1:63–67

    Google Scholar 

  23. Meladze GD, Mebuke MG, Chkhetiia NSh et al (1982) Efficacy of staphylococcal bacteriophage in the treatment of purulent lung and pleural diseases. Grudnaia Khirurgiia (Russian Breast Surgery) 1:53–56

    Google Scholar 

  24. Chkhetia NSh (1984) Treatment of lung diseases. CandSci Diss, Tbilisi, Georgia

    Google Scholar 

  25. Ermolieva VV (1939) About bacteriophage and its application. J Microbiol Epidemiol Immunol 9:9–17

    Google Scholar 

  26. Ruchko I (1936) Therapeutic effect of Staphylococcus phage for oral and dental infections. Sovetskaya Stomatologia (Russian “Soviet Stomatology”) 1:11–20

    Google Scholar 

  27. Krestovnikova VA (1947) Phage treatment and phage prophylactics and their approval in the works of the Soviet researchers. J Microbiol Epidemiol Immunol 3:56–65

    Google Scholar 

  28. Tsulukidze AP (1941) Experience of Use of Bacteriophages in the Conditions of War traumatism. Tbilisi, Georgia,  pp 418

    Google Scholar 

  29. Tucker JB (1999) Historical trends related to biorerrorism: An empirical analysis. Emerg Infect Dis 5:498–504

    Article  PubMed  CAS  Google Scholar 

  30. Palvin JA (1999) Epidemiology of bio-terrorism. Emerg Infect Dis 5:528–530

    Article  Google Scholar 

  31. Moores LE (2002) Threat credibility and weapons of mass destruction. Neurosurg Focus 12(3):E4

    PubMed  Google Scholar 

  32. Blendon RJ, Benson JM, DesRoches CM et al (2002) The impact of anthrax attacks on the American public. Medscape Gen Med 4(2):1

    Google Scholar 

  33. Relman DA, Olson JE (2001) Bioterrorism preparedness: what practitioners need to know. Infect Med 18:497–514

    Google Scholar 

  34. Alexandrova MB (1935) Phage therapy against dysentery. J Microbiol Epidemiol Immunol 11:860–868

    Google Scholar 

  35. Lurie MN (1938) Treatment of dysentery and haemolytic intestinal diseases among children and adults. Selected Papers of Azerbaijani Institute of Epidemiology and Microbiology 6:31–34

    Google Scholar 

  36. Vlasov KF, Artemenko EA (1946) Treatment of chronic dysentery. Sovetskaia Meditsina (Russian “Soviet Medicine”) 10:22–28

    Google Scholar 

  37. Gnutenko MP (1951) Treatment of S. typi and paratyphi bacterial carriers with bacteriophages. J Microbiol Epidemiol Immunol 5:56–60

    Google Scholar 

  38. Anpilov LI, Prokudin AA (1984) Preventive effectiveness of dried polyvalent Shigella bacteriophage in organized collective farms. Voenno-Meditsinskii Zhurnal (Russian “Military-Med J”) 5:39–40

    Google Scholar 

  39. Agafonov VI, Liashenko NI, Novikov NL (1984) Epidemiology of typhoid-paratyphoid infections and their prophylactics. Voenno-Meditsinskii Zhurnal (Russian “Military-Med J”) 6:36–40

    Google Scholar 

  40. Kurochka VK, Karniz AF, Khodyrev AP (1987) Experience in conducting epidemic-control measures in a focus of intestinal infections with a water mechanism of transmission. Russian “Military-Med J” 7:36–37

    Google Scholar 

  41. Pavlenishvili I (1988) Method of selective decontamination in newborns clinic. Certificate of Invention №269

    Google Scholar 

  42. Glonti T (2004) Study of the biological properties of bacteriophages active against P. aeruginosa and evaluation of their potential use for sanitation of the environment. CandSci dissertation, Tbilisi, Georgia

    Google Scholar 

  43. Chanishvili N, Glonti T (2007) Method of disinfection or decontamination of infected pen or building interior using bacteriophages. Patent AU 2007 9051U, Official Bulletin of Industrial Property 15:22

    Google Scholar 

Download references

Acknowledgments

This review was supported by the ISTC Partner Program Grant G-1467 and the UK Global Threat Reduction Programme.

Author information

Authors and Affiliations

  1. Eliava Institute of Bacteriophage, Microbiology and Virology (IBMV), 3 Gotua street, Tbilisi, 0160, Georgia

    N. Chanishvili

Authors
  1. N. Chanishvili
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Chanishvili .

Editor information

Editors and Affiliations

  1. School of Pharmacy &, Biomolecular Sciences, University of Brighton, Lewes Road, Brighton, East Sussex, BN2 4GJ, United Kingdom

    Sergey Mikhalovsky

  2. Center for Emergency Medicine, Ministry of Public Health, Republican Specialised Scientific, Tashkent, 100115, Uzbekistan

    Abdukhakim Khajibaev

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this paper

Cite this paper

Chanishvili, N. (2011). Biological Means Against Bio-Terrorism: Phage Therapy and Prophylaxis Against Pathogenic Bacteria. In: Mikhalovsky, S., Khajibaev, A. (eds) Biodefence. NATO Science for Peace and Security Series A: Chemistry and Biology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0217-2_13

Download citation

Publish with us

Policies and ethics

Search

Navigation